Efficacy and Safety of Adalimumab in Inducing Clinical Remission in Crohn's Disease: A Meta-Analysis With Subgroup Analysis

Basit Öğe Kaydı
dc.contributor.authorAksan, Feyzullah
dc.contributor.authorTanriverdi, Lokman Hekim
dc.contributor.authorMonzur, Farah
dc.date.accessioned2026-04-04T13:33:04Z
dc.date.available2026-04-04T13:33:04Z
dc.date.issued2023
dc.departmentİnönü Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.doi10.14309/01.ajg.0000953536.52666.0f
dc.identifier.endpageS735
dc.identifier.issn0002-9270
dc.identifier.issn1572-0241
dc.identifier.issue10S
dc.identifier.orcid0000-0003-4263-5234
dc.identifier.startpageS735
dc.identifier.urihttps://doi.org/10.14309/01.ajg.0000953536.52666.0f
dc.identifier.urihttps://hdl.handle.net/11616/108889
dc.identifier.volume118
dc.identifier.wosWOS:001538973400016
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofAmerican Journal of Gastroenterology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250329
dc.titleEfficacy and Safety of Adalimumab in Inducing Clinical Remission in Crohn's Disease: A Meta-Analysis With Subgroup Analysis
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu